Mufg Securities Emea PLC Abb Vie Inc. Transaction History

Mufg Securities Emea PLC

$2.55 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$154.79 - $180.76 $23.2 Million - $27.1 Million	149,999 New	149,999 $25.7 Million
Q4 2023 Feb 12, 2024	BUY	$137.6 - $154.97 $19.3 Million - $21.7 Million	140,000 New	140,000 $21.7 Million
Q2 2023 Aug 03, 2023	BUY	$132.51 - $164.9 $19.7 Million - $24.5 Million	148,665 New	148,665 $20 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $12,661 - $16,096	-92 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$131.98 - $163.75 $93,705 - $116,262	-710 Reduced 88.53%	92 $15,000
Q4 2021 Feb 11, 2022	SELL	$107.43 - $135.93 $26.3 Million - $33.3 Million	-244,998 Reduced 99.67%	802 $109,000
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $25.5 Million - $28.9 Million	-239,500 Reduced 49.35%	245,800 $26.5 Million
Q2 2021 Jul 19, 2021	BUY	$105.21 - $117.21 $25.7 Million - $28.6 Million	244,121 Added 101.22%	485,300 $54.7 Million
Q1 2021 May 11, 2021	SELL	$102.3 - $112.62 $31.1 Million - $34.2 Million	-303,821 Reduced 55.75%	241,179 $26.1 Million
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $28.2 Million - $38.1 Million	350,556 Added 180.29%	545,000 $58.4 Million
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $25.9 Million - $30.4 Million	-301,600 Reduced 60.8%	194,444 $17 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $36.4 Million - $48.7 Million	496,044 New	496,044 $48.7 Million
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $24.1 Million - $29 Million	-382,899 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $5.45 Million - $6.96 Million	82,899 Added 27.63%	382,899 $27.8 Million
Q1 2019 May 14, 2019	BUY	$77.14 - $90.79 $18.9 Million - $22.2 Million	245,000 Added 445.45%	300,000 $24.2 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $5.38 Million - $6.63 Million	-69,051 Reduced 55.66%	55,000 $5.07 Million
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $10.9 Million - $12.1 Million	122,353 Added 7205.71%	124,051 $11.7 Million
Q2 2018 Aug 01, 2018	BUY	$89.78 - $106.23 $152,446 - $180,378	1,698 New	1,698 $157,000
Q1 2018 May 01, 2018	SELL	$92.01 - $123.21 $27.6 Million - $37 Million	-300,000 Closed	0 $0
Q4 2017 Feb 06, 2018	BUY	$89.56 - $98.21 $26.9 Million - $29.5 Million	300,000	300,000 $29 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mufg Securities Emea PLC, based on Form 13F filings with the SEC.

News

Stay updated on Mufg Securities Emea PLC with notifications on news.

Account